Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.730
-0.050 (-2.81%)
At close: Oct 17, 2025, 4:00 PM EDT
1.730
0.00 (0.00%)
Pre-market: Oct 20, 2025, 8:00 AM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $280.17 million as of October 20, 2025. Its market cap has decreased by -87.47% in one year.
Market Cap
280.17M
Enterprise Value
82.54M
1-Year Change
-87.47%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $280.17M, a decrease of -89.15%. That is a compound annual growth rate of -65.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 280.17M | -83.64% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |